Colony Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Colony Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,011	Closed	-$256K	–	805
2022 Q2	$256K	Sell	4,011 -54	-1%	-$3.43K	﹤0.01%	723
2022 Q1	$263K	Sell	4,065 -48	-1%	-$3.04K	﹤0.01%	755
2021 Q4	$274K	Buy	+4,113	New	+$261K	﹤0.01%	713
2021 Q1	–	Sell	-16,857	Closed	-$1.01M	–	770
2020 Q4	$1.01M	Buy	+16,857	New	+$961K	0.02%	368
2019 Q1	–	Sell	-167,052	Closed	-$7.84M	–	646
2018 Q4	$7.84M	Buy	+167,052	New	+$8.56M	0.38%	78

Other funds holding IHE

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Colony Group's IHE Position: Q3 2022 in Review

Colony Group sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2022, closing a stake of 4,011 shares — an estimated $256K sold.

Colony Group first reported a position in IHE in Q4 2018 and held it in 5 quarters. The position peaked at $7.84M in Q4 2018. 113 funds tracked by Wall St. Rank hold IHE as of Q3 2022.

Colony Group reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Colony Group sold 4,011 iShares US Pharmaceuticals ETF shares in Q3 2022, an estimated $256K.
Colony Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2018 and held it in 5 quarters.
Colony Group's iShares US Pharmaceuticals ETF position peaked at $7.84M in Q4 2018.
113 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2022.

Based on Colony Group's 13F filing for Q3 2022, filed 15 Nov 2022.